FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

16553211000001105: Marvelon tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57889801000001110 Marvelon tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57889901000001116 Marvelon tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Desogestrel false Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Desogestrel true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Is a Marvelon true Inferred relationship Existential restriction modifier
Marvelon tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Marvelon tablets (Mawdsley-Brooks & Company Ltd) 63 tablet Has AMP True Marvelon tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start